China conditionally approves four self-developed COVID-19 vaccines: official
Share - WeChat


BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- China activates Level-IV emergency flood-control response in Hainan
- Flash flood leaves eight campers dead and four missing
- Helsinki spotlight for Beijing school's AI project
- Pioneering work on world's four major bay areas released
- Eight dead, four missing after Inner Mongolia flash flood
- China renews blue alert for rainstorms